HIV infection inhibitors
US6429308B1 · kind B1 · utility
10Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 2000 |
| Grant date | Aug 6, 2002 |
| Priority date | — |
| Expiry date | Jul 21, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antisense oligonucleotide characterized in that it hybridizes specifically with chromosomal DNA and/or RNA encoding CXCR4 protein to thereby inhibit the expression of the CXCR4 protein, and a HIV infection inhibitor comprising the antisense oligonucleotide, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.